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A Commentary on
The Moral Obligation to Prioritize Research Into Deep Brain Stimulation Over Brain Lesioning 
Procedures for Severe Enduring Anorexia Nervosa
by Pugh J, Tan J, Aziz T, Park RJ. Front Psychiatry (2018) 9:523. doi: 10.3389/fpsyt.2018.00523
Severe enduring anorexia nervosa (SEAN) has the highest mortality rate of all mental disorders, and 
existing treatments have limited efficacy (1). Therefore, clinical researchers are morally obliged to follow 
all possible avenues into the development of an effective therapy. A recent Frontiers Perspective is 
mistaken when it states that “lesioning procedures in (SEAN) are unethical at this stage of knowledge” (2).
This perspective rightly raises concerns that, in a recent Chinese study on capsulotomy for 
anorexia, patient selection was at odds with published guidelines from Western institutions (3). 
However, it conflates this issue with the ethics of research into stereotactic ablation for SEAN in 
general. Moreover, it places exclusive emphasis on the advantages of deep brain stimulation (DBS). 
Here we highlight a few of the advantages of stereotactic ablation, when compared with DBS, that 
were glossed over or entirely ignored (Table 1). Ethical research into both stereotactic ablation and 
DBS should be taken forward. It should be for informed patients to decide which they prefer.
The number of patients reported to have undergone DBS for anorexia is small, making it very difficult 
to comment on the possible spectrum of adverse events in practice. The largest series to date included 16 
patients; reported adverse events were seizures, air embolism, hardware infection, and malfunction (4).
Other than a single case report (with no complications), the experience of capsulotomy in patients 
with anorexia is limited to the aforementioned Chinese study; in a series of 74 patients, disinhibition, 
memory loss, and lethargy were reported but without any indication of the degree of severity (3, 5). The 
risk of adverse neuropsychological effects is often cited by psychiatrists as the main reticence for referral 
for ablative stereotactic procedures. However, a closer look at capsulotomy in other mental disorders 
may suggest otherwise. Studies that include detailed neuropsychological testing before and after 
capsulotomy in obsessive compulsive disorder (OCD) and depression often report improvement (fluency, 
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inhibition function, set-shifting, decision-making, and IQ scores) 
(6, 7) or no significant change (personality testing, executive 
functions, memory, concentration, and attention) (7, 8) in 
neuropsychological domains. Indeed, when neuropsychological 
side effects do occur (memory problems, cognitive impairment, 
personality change), they appear to be associated with large, 
dorsally placed lesions and excessively high radiation doses during 
gamma knife capsulotomy (9–11). Clinical and neuroimaging 
studies suggest that ventrally placed lesions in the anterior capsule 
provide good efficacy with low rates of adverse effects (7, 11).
One of the basic ethical principles of research is to minimize 
risk to participants. While DBS has an excellent safety track 
record, stereotactic ablation may carry less surgical risk in anorexia 
patients. Ablation can be performed under local anesthesia 
without the need for general anesthesia—a significant advantage 
when multisystem abnormalities carry important anesthetic 
implications (12). Additionally, DBS carries a risk of hardware 
infection or skin erosion and has a much greater cosmetic impact 
than ablation, an important factor for some individuals with SEAN 
and body image concerns. Moreover, monitoring and follow-up in 
centralized specialist services involves considerable commitment 
of travel time, effort, and expense for these potentially frail 
vulnerable patients, some of whom live in remote and rural areas.
Much emphasis is placed upon the “reversibility” of DBS, which 
is definitely true of the first few weeks or months. However, we must 
also acknowledge that DBS is not reversible after a few months or 
years. For example, switching off DBS in patients with obsessive 
compulsive disorder (OCD) can result in deterioration of affective 
symptoms that exceed presurgery levels (13). Switching off DBS 
in patients with Parkinson’s disease or dystonia  can lead to fatal 
parkinsonian or dystonic crisis (14–17). While stereotactic ablation 
is a one-off procedure, the risk of rebound or recurrence of symptoms 
makes DBS a lifelong commitment, raising additional ethical issues 
about lifelong surgical aftercare. Who assumes responsibility for 
pulse-generator replacement or repair of device malfunction after 
the trial has closed and the investigators have left the trial institution?
The high cost of DBS as compared to ablation raises other 
ethical issues. Currently, evidence from randomized controlled 
trials supports both stereotactic ablation (18) and DBS in 
the management of OCD (19–21). Nevertheless, stereotactic 
ablation is the only surgical therapy for OCD currently available 
within the British National Health Services. Cost is likely to be at 
least one of the factors leading to this situation. One could argue 
that it is more ethical to perform research into a therapy that is 
more likely to come to those who need it, whether within the 
UK or indeed globally. DBS is beyond the financial reach of most 
countries and individuals.
The Frontiers Perspective states: “there are no published 
systematic comparisons between DBS and ablative neurosurgery 
for any psychiatric indication.” This is not the case. Indeed, a recent 
review of surgery for OCD suggests that capsulotomy provides a 
number of advantages over DBS at the same anatomical target 
(22). In one study, two of three patients whose OCD symptoms 
were refractory to DBS subsequently responded to stereotactic 
ablation at the same anatomical target (19). Therefore, a negative 
trial of DBS does not discount the possibility of a positive trial 
of stereotactic ablation at the same target, further supporting 
concurrent research into both surgical approaches.
Reference is made to a case report of capsulotomy in an 
individual with comorbid anorexia nervosa and OCD who 
experienced significant improvement in both conditions (5). 
Bizarrely, this is used as evidence against stereotactic ablation 
since, at the 3-month time point, the patient felt negatively about 
the procedure, despite being very positive about the surgery at 
the 1-year time point. It is not at all uncommon for patients to be 
ambivalent about having undergone surgery in retrospect, even 
after well-established (irreversible) surgical procedures. Clearly, 
this is not a good reason to discontinue the approach as long as 
comprehensive informed consent is part of the process.
The Perspective piece suggests that DBS is “a dynamic 
process in which the patient is actively involved in making 
on-going decisions.” Individuals who value this approach may 
TABLE 1 | Potential advantages and disadvantages of stereotactic radiofrequency ablation and deep brain stimulation (DBS) for anorexia.
Stereotactic radiofrequency ablation Deep brain stimulation
Mode of anesthesia Local anesthetic may be safer in patients with 
multisystem abnormalities
General anesthetic is required and may carry additional 
anesthetic risks
Risk of infection Very low risk Infection may result in withdrawal of therapy if hardware has to 
be removed
Hardware-related problems No risk Risk of skin erosion, lead fracture, pulse-generator malfunction 
resulting in withdrawal of therapy and requiring further surgery
Hardware maintenance No risk Ethical issues about lifelong surgical aftercare; commitment to 
further surgical procedures for pulse-generator replacement
Body image concerns related to surgery Less problematic Potentially more problematic with scars and implanted hardware 
on torso
Adverse neuropsychological effects Potential for irreversible changes Likely to be reversible
Reversibility Not reversible Early reversibility; potential for long-term DBS “dependence” and 
symptom rebound
Issues of “control” Some individuals may not want to undergo 
stereotactic ablation 
Implanted device may be seen as a form of “physician control”; 
others may feel actively involved in making ongoing decisions
Specialist follow-up One-off surgical procedure; follow-up by anorexia 
team
Considerable commitment to lifelong follow-up in centralized 
functional neurosurgery center plus follow-up by anorexia team
Cost Relatively cheap Relatively expensive; less likely to become widely available to 
patients, even if shown to be effective
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opt to participate in a trial of DBS. However, others might 
prefer the option of a single procedure without the need for 
repetitive hospital appointments to “tweak” stimulation or of 
committing to further inevitable surgical interventions. Such 
persons would also be exercising active choice when choosing 
to enroll in a trial of stereotactic ablation that is governed 
by  ethical safeguards to firmly ensure that they would not 
submit passively.
It has been highlighted that individuals with SEAN place 
great value on control. Whether an individual is contemplating 
enrolment in a trial of DBS or stereotactic ablation, a fully 
informed adult, with capacity to give consent, can exercise that 
control by agreeing or declining to participate in that particular 
study. Freely making long-term or irreversible commitments 
is itself an important exercise of autonomy. Thus, preventing 
SEAN patients from making irreversible choices in the name 
of protecting their control could be a form of disrespect for 
autonomy.
The Perspective presents the very valid opinion of a self-
selected group of individuals who have agreed to participate 
in a trial of DBS. However, when we conducted focus groups 
with SEAN individuals, opinions included those against any 
sort of surgery, some interested in DBS, and others positive 
about entering a trial of stereotactic ablation (unpublished 
work). “Many with SEAN have few options remaining to 
them and feel hopeless.” Trying to restrict surgical research 
in  SEAN  to  DBS places further limits on the choice of 
individuals who place great value on control, have few options, 
and feel hopeless.
Finally, we wish to emphasize that we fully support ethical 
research into DBS for SEAN and for other mental disorders. 
Indeed, while our group provides a national stereotactic ablation 
service for severe refractory OCD and depression, we have also 
conducted a number of trials of DBS in mental disorders (23–25). 
We have considerable experience of the potential advantages 
and disadvantages of both approaches. It is true that stereotactic 
ablation raises ethical considerations over and above those raised 
by DBS. However, as demonstrated above, the converse is also true.
Ultimately, well-informed adult participants with capacity 
should be free to decide whether or not they wish to participate 
in a particular ethically approved research project. Individuals 
with SEAN might view the balance of risks of stereotactic 
ablation as preferable to DBS in their particular situation. It is 
inappropriately paternalistic to dictate otherwise.
We applaud the Oxford group for their pioneering work on 
DBS for SEAN in the UK. However, bias toward research into 
DBS has no rational, moral, or ethical basis. Suppressing either 
of the surgical approaches at this stage of research is potentially 
damaging to research in a field that is in desperate need of novel 
and effective therapies.
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